Dependence AddictiveAIANCT04954027
Attachment and Prognostic Factor: the Implicit Approach
An observational study of Dependence Addictive, run by Centre Hospitalier Henri Laborit.
Trial summary
This is a prospective longitudinal study aimed at better understanding the determinants of the prognosis of patients with substance dependence. 5 visits are planned during the study : the inclusion visit : during this visit the patient's non-opposition is obtained and then the patient answer to self-administered… Read more about this study
- Who is it for?
- Ages 18 to 65 years
- Conditions the study is for
- Dependence Addictive
- What is being tested?
- Questionnaires
- Type of treatment
- Lifestyle or therapy programme
- How many people
- 200 participants
- Where
- No sites listed yet
- Study dates
- Sep 2027to Sep 2029
- Phase
- Observational
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 65 years
- All sexes
- No healthy volunteers
- Adult, Older adult
Study population: Patients with a use-related disorder weaning for a substance, supported within the addictology sector of Henri Laborit Hospital
Who may be able to join
- Patients between 18 and 65 years old
- Patients with a use-related disorder as defined by DSM5
- Patients weaning for a substance, supported within the addictology sector of Henri Laborit Hospital
- Having expressed non-opposition to participating in the study after receiving written information.
Who cannot join
- Person who cannot read or write
- Simultaneous participation in a therapeutic trial involving oxytocin
- Patients protected by law
- Patients who do not have French as their native language
- Patients who, in the opinion of the investigator, are unable to complete the questionnaires
Trial locations and contacts
No sites are listed yet. Contact the study team or a site near you to ask about taking part.
About this study
Official title: Place of Attachment as a Post-weaning Prognostic Factor: Interest of the Implicit Approach
This is a prospective longitudinal study aimed at better understanding the determinants of the prognosis of patients with substance dependence.
5 visits are planned during the study :
- the inclusion visit : during this visit the patient's non-opposition is obtained and then the patient answer to self-administered questionnaires online
- 4 telephone interviews for follow-up by investigator.
- Conditions
- Dependence Addictive
- Being tested
- Questionnaires
- Keywords
- implicit approach, post-weaning prognostic factor
- Medical subject headings
- Behavior, Addictive
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
QuestionnairesBehavioural
5 visits are planned during the study :
- the inclusion visit : during this visit the patient's non-opposition is obtained and then the patient answer to self-administered questionnaires online
- 4 telephone interviews for follow-up by investigator
| Study group | Role | What they receive |
|---|---|---|
| Patients with a use-related disorder weaning for a substance | Not described Receives: Behavioral: Questionnaires |
What is being measured
The primary outcome is the main question the study is designed to answer.
Implicit attachment and onsumption
Assessment of the link between implicit attachment and changes in consumption after a 12-month follow-up
Measured: 12 months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted8 Jul 2021
- Study startSep 2027 (estimated)
- Primary completionSep 2029 (estimated)
- Study completionSep 2029 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Dependence AddictiveStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 200 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Centre Hospitalier Henri Laborit
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
- Investigators
- Wilfried SERRA, Dr, Principal investigator, Centre Hospitalier Henri Laborit
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT04954027
- Sponsor's protocol ID
- 2021-A00432-39
- Acronym
- AIA
- Status last verified
- Oct 2026
- First submitted
- 29 Jun 2021
- Last updated
- 23 Oct 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 23 Oct 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Place of Attachment as a Post-weaning Prognostic Factor: Interest of the Implicit Approach
- ClinicalTrials.gov ID
- NCT04954027
- Acronym / sponsor ID
- AIA / 2021-A00432-39
- Conditions
- Dependence Addictive
- Keywords
- implicit approach, post-weaning prognostic factor
- Study type
- Observational
- Recruitment status
- Not yet recruiting
- Enrolment
- 200 participants (estimated)
- Lead sponsor
- Centre Hospitalier Henri LaboritUniversity, hospital or other
- Study start
- Sep 2027 (estimated)
- Primary completion
- Sep 2029 (estimated)
- Study completion
- Sep 2029 (estimated)
- First posted
- 8 Jul 2021 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This is a prospective longitudinal study aimed at better understanding the determinants of the prognosis of patients with substance dependence.
5 visits are planned during the study :
- the inclusion visit : during this visit the patient's non-opposition is obtained and then the patient answer to self-administered questionnaires online
- 4 telephone interviews for follow-up by investigator.
Study design
- Observational model
- Cohort
- Time perspective
- Prospective
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Patients with a use-related disorder weaning for a substance | – | Behavioral: Questionnaires |
Who may qualify
- Ages
- 18 to 65 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
- Study population
- Patients with a use-related disorder weaning for a substance, supported within the addictology sector of Henri Laborit Hospital
Key inclusion criteria (4 listed)
- Patients between 18 and 65 years old
- Patients with a use-related disorder as defined by DSM5
- Patients weaning for a substance, supported within the addictology sector of Henri Laborit Hospital
- Having expressed non-opposition to participating in the study after receiving written information.
Key exclusion criteria (5 listed)
- Person who cannot read or write
- Simultaneous participation in a therapeutic trial involving oxytocin
- Patients protected by law
- Patients who do not have French as their native language
- Patients who, in the opinion of the investigator, are unable to complete the questionnaires
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Questionnaires5 visits are planned during the study : * the inclusion visit : during this visit the patient's non-opposition is obtained and then the patient answer to self-administered questionnaires online * 4 telephone interviews for follow-up by investigator | Behavioural | Patients with a use-related disorder weaning for a substance |
Primary outcome
Implicit attachment and onsumption
Time frame: 12 months
Assessment of the link between implicit attachment and changes in consumption after a 12-month follow-up
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 23 Oct 2026.
- Individual participant dataSharing planned: No
Related trials for Dependence Addictive
RecruitingObservational study
Outcome Inference in the Sensory Preconditioning Task in Opioid-Use Disorder
Opioid-Related Disorders, Drug Addiction
Recruiting
Fighting Addictions, Improving Lives: COmprehensive Drug Rehabilitation With Music
Substance Use Disorder (SUD)
Recruiting
Support Towards Addiction Recovery for Individuals With Criminal Legal System Involvement: The STAR Project
Addiction
Not yet recruiting
Evaluation of Interventions to Promote Work-Life Balance Among Students at Gaming Schools
Internet Gaming Disorder
Recruiting
Rural Community Peer Partnerships for Improving Methamphetamine-Associated Heart Failure Screening and Engagement
Methamphetamine Use, Heart Failure
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
Wilfried SERRA, Dr principal investigator
Centre Hospitalier Henri Laborit
Questions about this trial
What is this clinical trial studying?
An observational study of Dependence Addictive, run by Centre Hospitalier Henri Laborit.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 4 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: opening soon, as of the sponsor's last update on 23 Oct 2026. Status can change between updates, so confirm with the study contact before making plans.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Wilfried SERRA, Dr (0033 5 16 52 61 18, wilfried.serra@ch-poitiers.fr), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Implicit attachment and onsumption (time frame: 12 months). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 23 Oct 2026.